07/13/13  Portland, Ore.

Marka Crittenden, MD, PhD. a 2010 graduate of the residency training program of the OHSU Dept of Radiation Medicine, received a highly competitive R21 research grant [1R21 CA176705] from the NCI. Her grant is titled "CLINICAL & IMMUNOLOGICAL EFFECTS OF SBRT AD IL-2 IN METASTATIC MELANOMA". 

Dr. Crittenden, a physician-scientist with advanced training in tumor immunology was one of the first OHSU residents in the American Board of Radiology's B. Leonard Holman Pathway. During her training, Dr. Crittenden received a Resident/Fellow Research Grant from the RSNA.